Multi-Modal AI Analysis Technology Aids Precision Prediction of Treatment Response in HER2-Positive Gastric Cancer Patients
On August 26, 2024, Professor Shen Lin’s team from Peking University Cancer Hospital and Professor Dong Bin’s team from Peking University published a groundbreaking research article titled “Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data” in Signal Transduction and Targeted Therapy (Impact Factor: 40.8). This study developed a … Read more